Senior Vice President for Health Affairs, CEO UHealth-University of Miami Health System
Steven M. Altschuler, M.D. joined the University of Miami as senior vice president of health affairs at the University of Miami and chief executive officer of UHealth-University of Miami Health System in January 2016 after serving as president and chief executive officer of The Children’s Hospital of Philadelphia (CHOP) and The Children’s Hospital Foundation for the past 15 years.
Altschuler is responsible for the strategic and operational leadership of the University’s clinical delivery system, which includes the University’s hospitals, faculty practice plan, and clinics. He also provided strategic leadership to align clinical and research investments.
As South Florida’s only academic-based health system, UHealth combines patient care, research, and education to create a leading-edge approach to health care. UHealth’s comprehensive network includes three hospitals: Sylvester Comprehensive Cancer Center, University of Miami Hospital, and Bascom Palmer Eye Institute; more than two dozen outpatient facilities in Miami-Dade, Broward, Palm Beach, and Collier counties, with more than 1,500 physicians and scientists and 8,000 staff.
Altschuler received his B.A. in mathematics from Case Western Reserve University and his M.D. from the Case Western Reserve University School of Medicine. He was an intern and resident at Children’s Hospital Medical Center in Boston, before serving as a postdoctoral fellow at CHOP.
Altschuler led CHOP’s transformation from a traditional academic medical center into a world leader in pediatric health care, research, education, and advocacy for children, with strong ties to the University of Pennsylvania. The organization has approximately 14,000 employees, including nearly 1,200 full-time physicians and researchers, at 50 different care sites in Pennsylvania and New Jersey. In FY 2015, the foundation, hospital, and affiliates had approximately $5.4 billion in assets and $115 million in charitable contributions. Research expenditures were approximately $340 million, and the hospital supported the clinical and research training of 135 residents and 275 fellows. Since 2003, with the exception of only two years, U.S. News & World Report has ranked CHOP the No. 1 children's hospital in the nation.
Dr. Altschuler was associated with CHOP as a postdoctoral fellow in 1982, becoming an assistant physician in 1984 and serving as chair of the Department of Pediatrics and physician-in-chief of CHOP from 1997-2000. He also was a faculty member in the Department of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania from 1985-2000. Since retiring from CHOP in June 2015, Dr. Altschuler has been board chair of Spark Therapeutics, a leading gene therapy company that is a spinoff of the Center of Cellular and Molecular Therapeutics at CHOP.